Women Injured By YAZ, Yasmin, Ocella Can Get Free Case Review
TortLawNetwork.com announces that women injured by YAZ, Yasmin or Ocella can now get a free case review.
Women who have been suffering severe side effects due to this drug, can pursue legal action in order to receive compensation for the damage done. .
Medical YAZ Problems
YAZ, Yasmin and Ocella (generic version), is a birth control pill that women took without being told of all the potential risks and side effects.
Women throughout the country are experiencing major reactions to this drug, including an increased risk (six to seven times in fact) of developing thromboembolism compared to women who do not take the pill. Thromboembolism is a type of blood clot.
YAZ is also responsible for an increased risk of hyperkalemia (which can cause abnormal hearth rhythms) in high-risk patients.
Some common injuries may include:
- Deep vein thrombosis
- Pulmonary embolism
- Heart attack
- Cardiovascular injury
- Kidney failure
- Blood clot related injuries
- Heart arrhythmia
- Gall bladder injury/removal
Legal YAZ Solutions
In case you didnít know, the U.S. Federal Drug Administration has issued warnings about the safety of Yaz, Yasmin and Ocella after receiving multiple reports of patients suffering serious injury or death after taking the drug.
Due to the failure of Bayer, the maker of YAZ, to properly warn patients about the health risks, are liable for the injuries and damages caused.
Lawyers are currently helping thousand of women affected by the drug to file lawsuits for theirs medical costs, lost wages, and pain and suffering.
If you believe you suffered severe side effects from taking these heavily advertised drugs, contact Tort Law Network today. You may be entitled to substantial compensation; however, time to file a claim is limited.
For more information and to receive a free case review, go to www.tortlawnetwork.com or call 866-792-1925.
- Contact Information
- Michael Taylor
- Media Contact
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.